Objective: To provide information and recommendations to women with a previous
diagnosis of breast cancer and their physicians regarding hormone replacement therapy …

BACKGROUND Currently the use of hormone replacement therapy (HRT) in women with a
history of previous breast cancer is absolutely contraindicated despite there being a lack of …

A previous history of breast cancer has long been considered a contra-indication for
hormone replacement therapy (HRT), mainly because it has been feared that HRT may …

It is now well established that replacement therapy with estrogen is an effective tool to
manage menopausal symptoms. There is also increasing evidence that hormone …

From the introduction of post-menopausal hormone replacement therapy (HRT) there has
been great concern that HRT could possibly increase the risk of breast cancer. Prolonged …

This article reviews the decades of evidence supporting the reproducible benefits of HRT for
menopausal symptom control, improved cardiac health, prevention of hip fracture, reduction …

PURPOSE To review critically the literature regarding effects of estrogen replacement
therapy (ERT)/combined estrogen and progesterone replacement therapy (HRT) on the risk …

Large-scale randomized clinical trials and observational studies have consistently found that
use of hormone replacement therapy (HRT) increases the risk of breast cancer. More …

Background. It has been common practice to prohibit hormone‐replacement therapy (HRT)
in patients with breast cancer. A reappraisal of this practice is necessary because hundreds …

Hormone-replacement therapy (HRT) has been available for many years, but the important
question of its place in development and progression of breast cancer remains controversial; …